Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 28, 2024 -- Children with prenatal cannabis exposure exhibit some differences in aspects of executive function and behavior, according to a study published online Oct. 28 in JAMA Pediatrics.
Sarah A. Keim, Ph.D., from The Abigail Wexner Research Institute at Nationwide Children's Hospital in Columbus, Ohio, and colleagues prospectively examined the association of prenatal cannabis exposure with executive function and aggressive behavior at age 5 years in a cohort study conducted from 2016 through 2020. A total of 355 participants were enrolled in a pregnancy research repository and were invited to participate again when the child was 5 years of age.
The researchers found that 80 of 250 children (32 percent) were exposed to cannabis. Use of tobacco, other drugs, and alcohol during pregnancy occurred in 22 to 39 percent of participants. Most of the included families were living in poverty. Following propensity score weighting and adjustment for confounders, age-corrected standard scores for children's attention and inhibitory control were about 0.4 standard deviations lower for those exposed to cannabis versus those unexposed. Poorer task-based planning ability and more observed aggression was also exhibited by exposed children. No differences were seen by exposure status for caregiver ratings of executive function and behavior and laboratory assessments of other aspects of executive functioning.
"The present findings may inform counseling by clinicians to avoid cannabis use during pregnancy, particularly given its recent increase," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-29 12:00
Read more
- AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease
- FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease
- Darling Ingredients Announces Publication of Peer-Reviewed Collagen Peptides Study and its Impact on Post-Meal Blood Glucose Spikes
- Outbreak of Ebola-Like Marburg Virus in Rwanda Has Killed 8 People
- Standing More During the Day Does Not Cut Cardiovascular Risk
- Iowa Resident Dies of Suspected Lassa Fever After Trip to West Africa
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions